2/28
05:59 am
lexx
Lexaria Bioscience: Oral Drug Delivery Technology Targets Next-Gen Weight Loss Market [Globe and Mail, The (Toronto, Canada)]
Low
Report
Lexaria Bioscience: Oral Drug Delivery Technology Targets Next-Gen Weight Loss Market [Globe and Mail, The (Toronto, Canada)]
2/28
05:59 am
lexx
Lexaria Bioscience: Improving Oral Weight-Loss Drug Tolerability [Globe and Mail, The (Toronto, Canada)]
Low
Report
Lexaria Bioscience: Improving Oral Weight-Loss Drug Tolerability [Globe and Mail, The (Toronto, Canada)]
1/21
09:55 am
lexx
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
Medium
Report
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
12/31
09:37 am
lexx
Lexaria releases additional results from Phase 1b study GLP-1-H24-4 [Yahoo! Finance]
High
Report
Lexaria releases additional results from Phase 1b study GLP-1-H24-4 [Yahoo! Finance]
12/26
07:17 am
lexx
Lexaria Bioscience (NASDAQ:LEXX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Lexaria Bioscience (NASDAQ:LEXX) had its "buy" rating reaffirmed by analysts at HC Wainwright.